DrugPatentWatch Database Preview
FOUGERA PHARMS Company Profile
» See Plans and Pricing
What is the competitive landscape for FOUGERA PHARMS, and what generic alternatives to FOUGERA PHARMS drugs are available?
FOUGERA PHARMS has one hundred and fourteen approved drugs.
There are four US patents protecting FOUGERA PHARMS drugs.
There are forty-two patent family members on FOUGERA PHARMS drugs in twenty countries and fifty-one supplementary protection certificates in sixteen countries.
Summary for FOUGERA PHARMS
| International Patents: | 42 |
| US Patents: | 4 |
| Tradenames: | 54 |
| Ingredients: | 46 |
| NDAs: | 114 |
Drugs and US Patents for FOUGERA PHARMS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | CALCIPOTRIENE | calcipotriene | SOLUTION;TOPICAL | 078305-001 | May 6, 2008 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Fougera Pharms Inc | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | SOLUTION;TOPICAL | 088167-001 | Dec 16, 1982 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Fougera Pharms | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 085691-003 | Approved Prior to Jan 1, 1982 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Fougera Pharms | METRONIDAZOLE | metronidazole | CREAM;TOPICAL | 076408-001 | May 28, 2004 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Fougera Pharms Inc | GENTAMICIN SULFATE | gentamicin sulfate | CREAM;TOPICAL | 062531-001 | Jul 5, 1984 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FOUGERA PHARMS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Fougera Pharms | TEMOVATE | clobetasol propionate | SOLUTION;TOPICAL | 019966-001 | Feb 22, 1990 | 3,721,687 | Start Trial |
| Fougera Pharms | SOLARAZE | diclofenac sodium | GEL;TOPICAL | 021005-001 | Oct 16, 2000 | 5,914,322 | Start Trial |
| Fougera Pharms | ACLOVATE | alclometasone dipropionate | CREAM;TOPICAL | 018707-001 | Dec 14, 1982 | 4,124,707 | Start Trial |
| Fougera Pharms | TEMOVATE | clobetasol propionate | CREAM;TOPICAL | 019322-001 | Dec 27, 1985 | 3,721,687 | Start Trial |
| Fougera Pharms | TEMOVATE | clobetasol propionate | OINTMENT;TOPICAL | 019323-001 | Dec 27, 1985 | 3,721,687 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for FOUGERA PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Lotion | 0.05% | ➤ Subscribe | 2008-07-28 |
| ➤ Subscribe | Topical Gel | 3% | ➤ Subscribe | 2009-12-16 |
International Patents for FOUGERA PHARMS Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | PI0214256 | Start Trial |
| European Patent Office | 0842660 | Start Trial |
| Japan | 4495459 | Start Trial |
| Australia | 4443897 | Start Trial |
| Hong Kong | 1131048 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for FOUGERA PHARMS Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1304992 | C300617 | Netherlands | Start Trial | PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322 |
| 1304992 | 2013C/060 | Belgium | Start Trial | PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506 |
| 1448186 | CA 2012 00040 | Denmark | Start Trial | |
| 1448186 | 300550 | Netherlands | Start Trial | PRODUCT NAME: DROOG EXTRACT VAN GROENE THEE (CAMELLIA SINENSIS (L.) O.KUNZE FOLIUM) WATERIG (24-56:1) WAARVAN 100 MG OVEREENKOMT MET : 55-72 MG VAN (-)- EPIGALLOCATECHINEGALLAAT. EERSTE EXTRACTIEMIDDEL: WATER; NATIONAL REGISTRATION NO/DATE: RVG 110904 20120920; FIRST REGISTRATION: DE 73486.00.00 20090831 |
| 0284288 | SPC/GB98/002 | United Kingdom | Start Trial | PRODUCT NAME: TAZAROTENE : ETHYL 6-(2-(4,4-DIMETHYLTHIOCHROMAN-6-YL) ETHYNYL) NICOTINOATE; REGISTERED: DE 37393.00.00 19961203; DE 37393.01.00 19961203; UK 00426/0097 19970730; UK 00426/0096 19970730 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
